4.8 Article

A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1

Journal

CANCER RESEARCH
Volume 68, Issue 14, Pages 5581-5590

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-07-6346

Keywords

-

Categories

Funding

  1. NCI NIH HHS [R01 CA096527-09, R01 CA096527-10, R01 CA096527-08, R01 CA096527-07, R01 CA096527-06A2, R01 CA096527, CA096527] Funding Source: Medline

Ask authors/readers for more resources

Cyclin G1 was identified as a transcriptional target of p53 that encodes a protein with strong homology to the cyclin family of cell cycle regulators. We show that either ectopically expressed or endogenous cyclin G1 protein is very unstable, undergoes modification with ubiquitin, and is likely degraded by the proteasome. Ectopic cyclin G1 protein stability is increased by cyclin box mutation or by association with inactive cyclin-dependent kinase (CDK) subunits, suggesting that a function of cyclin G1 as a CDK regulator may be required for its rapid turnover. Furthermore, cyclin G1 and the cyclin box mutant interact with and are ubiquitinated by MDM2, another transcriptional target of p53 that acts as a negative regulator of p53 stability. These data suggest that the cyclin box has a role in the proteasome-mediated degradation of cyclin G1 and thus suggest a putative rote for a CDK in cyclin G1 metabolism and function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available